Diabetes a obezita - Issue 38/2019
71
75
Gut microbiome in children and risk of developing type 1 diabetes mellitus
Uboš Ambro, Anna Kamlárová, René Link, Ivana Lukáčová, Alojz Bo, Oliver Rácz
90
Vliv léčby inzulinem Fiasp na glykemie, HbA1c a tělesnou hmotnost u osob s diabetem 1. a 2. typu: studie z reálné praxe
Rudolf Chlup, Jana Zapletalová, Hana Zálešáková, Johana Kochtová, Richard Kaňa
98
103
Adipocytokines as possible etiopathogenetic mechanisms leading to a higher incidence of autoimmune thyroiditis in patients with type 2 diabetes mellitus
Štefan Sotak, Zbynek Schroner, Ivica Lazúrová, Marek Felš Ci, Darina Petrášová, Izabela Bertková, Miriam Mitníková, Jozefína Petrovičová
110
Management of arterial hypertension in persons with type 2 diabetes mellitus
Udovít Gašpar, Slavomíra Filipová
115
118
121
Intensive glycemic compensation and prevention of chronic diabetic complications
Vladimír Uličiansky
127
129
131
Combination of basal insulin and metformin: a case report
Radovan Plášil
134
55. výročný kongres European Association for the Study of Diabetes
Peter Novodvorský, MUDr. Marta Korecová
136
140
79. konferencia American Diabetes Association
Viera Doničová
Diabetes a obezita
2019 Issue 38
Most read in this issue
- Vliv léčby inzulinem Fiasp na glykemie, HbA1c a tělesnou hmotnost u osob s diabetem 1. a 2. typu: studie z reálné praxe
- Has everything really been discovered about SGLT2 inhibitors?
- Early insulin treatment of a newly diagnosed type 2 diabetic patient: a case report
- Gut microbiome in children and risk of developing type 1 diabetes mellitus